Incremental value of insulin resistance surrogate indices beyond the CHA2DS2-VASc score for predicting thromboembolic events in patients with chronic heart failure and atrial fibrillation
Background Patients with chronic heart failure (CHF) and atrial fibrillation (AF) are at high risk of thromboembolic events. Although the CHA2DS2-VASc score is widely used for risk stratification, it may not fully capture metabolic dysfunction. Whether insulin resistance (IR) surrogate indices provide incremental infor...